These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 26507498)
1. Metabolic syndrome and the risk of breast cancer among postmenopausal women in North-West China. Wang M; Cheng N; Zheng S; Wang D; Hu X; Ren X; Pei H; Ma H; Mu H; Bai Y Climacteric; 2015; 18(6):852-8. PubMed ID: 26507498 [TBL] [Abstract][Full Text] [Related]
2. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it. Ruan X; Jin J; Hua L; Liu Y; Wang J; Liu S Menopause; 2010; 17(3):566-70. PubMed ID: 20054286 [TBL] [Abstract][Full Text] [Related]
3. Risk of metabolic syndrome in postmenopausal breast cancer survivors. Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866 [TBL] [Abstract][Full Text] [Related]
4. Association between body mass index and risk of formation of breast cancer in Chinese women. Chow LW; Lui KL; Chan JC; Chan TC; Ho PK; Lee WY; Leung LH; Sy WM; Yeung CC; Yung AK Asian J Surg; 2005 Jul; 28(3):179-84. PubMed ID: 16024311 [TBL] [Abstract][Full Text] [Related]
5. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. Montazeri A; Sadighi J; Farzadi F; Maftoon F; Vahdaninia M; Ansari M; Sajadian A; Ebrahimi M; Haghighat S; Harirchi I BMC Cancer; 2008 Sep; 8():278. PubMed ID: 18826621 [TBL] [Abstract][Full Text] [Related]
6. [Body mass index and cancer incidence:a prospective cohort study in northern China]. Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616 [TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Rosato V; Bosetti C; Talamini R; Levi F; Montella M; Giacosa A; Negri E; La Vecchia C Ann Oncol; 2011 Dec; 22(12):2687-2692. PubMed ID: 21415236 [TBL] [Abstract][Full Text] [Related]
8. Follicle-Stimulating Hormone, Its Association with Cardiometabolic Risk Factors, and 10-Year Risk of Cardiovascular Disease in Postmenopausal Women. Wang N; Shao H; Chen Y; Xia F; Chi C; Li Q; Han B; Teng Y; Lu Y J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855169 [TBL] [Abstract][Full Text] [Related]
9. The prevalence of metabolic syndrome in premenopausal and postmenopausal women in Southern Thailand. Jeenduang N; Trongsakul R; Inhongsa P; Chaidach P Gynecol Endocrinol; 2014 Aug; 30(8):573-6. PubMed ID: 24720345 [TBL] [Abstract][Full Text] [Related]
10. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene. Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658 [TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Petri Nahas EA; Padoani NP; Nahas-Neto J; Orsatti FL; Tardivo AP; Dias R Climacteric; 2009 Oct; 12(5):431-8. PubMed ID: 19415539 [TBL] [Abstract][Full Text] [Related]
12. The relationship between serum uric acid and metabolic syndrome in premenopausal and postmenopausal women in the Jinchang Cohort. He SJ; Chan C; Xie ZD; Shi D; Hu XB; Li HY; Wang D; Wang MZ; Bai YN Gynecol Endocrinol; 2017 Feb; 33(2):141-144. PubMed ID: 27558970 [TBL] [Abstract][Full Text] [Related]
13. Utility of obesity indices in screening Chinese postmenopausal women for metabolic syndrome. Liu P; Ma F; Lou H; Zhu Y Menopause; 2014 May; 21(5):509-14. PubMed ID: 23963310 [TBL] [Abstract][Full Text] [Related]
14. Diabetes, overweight and risk of postmenopausal breast cancer: a case-control study in Uruguay. Ronco AL; De Stefani E; Deneo-Pellegrini H; Quarneti A Asian Pac J Cancer Prev; 2012; 13(1):139-46. PubMed ID: 22502657 [TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Bjørge T; Lukanova A; Jonsson H; Tretli S; Ulmer H; Manjer J; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Häggström C; Stattin P; Engeland A Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1737-45. PubMed ID: 20615887 [TBL] [Abstract][Full Text] [Related]
16. Metabolic factors and breast cancer risk in Korean women. Noh HM; Song YM; Park JH; Kim BK; Choi YH Cancer Causes Control; 2013 Jun; 24(6):1061-8. PubMed ID: 23504150 [TBL] [Abstract][Full Text] [Related]
17. Body mass index had different effects on premenopausal and postmenopausal breast cancer risks: a dose-response meta-analysis with 3,318,796 subjects from 31 cohort studies. Chen Y; Liu L; Zhou Q; Imam MU; Cai J; Wang Y; Qi M; Sun P; Ping Z; Fu X BMC Public Health; 2017 Dec; 17(1):936. PubMed ID: 29216920 [TBL] [Abstract][Full Text] [Related]
18. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA; Borofsky ND; Massardo S; Orentreich N Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [TBL] [Abstract][Full Text] [Related]
20. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]